Clinical in-stent restenosis with bare metal stents: Is it truly a benign phenomenon?

International Journal of Cardiology

Volumn 128, Issue 3, 2008, Pages 378-382

  Bainey, Kevin R ^a   Norris, Colleen M ^a   Graham, Michelle M ^a   Ghali, William A ^b   Knudtson, Merril L ^b   Welsh, Robert C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Acute coronary syndrome; Clinical presentation; In stent restenosis

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ANGIOGRAPHY; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RESTENOSIS; STENT; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; METALS; MIDDLE AGED; PROSPECTIVE STUDIES; STENTS; TIME FACTORS;

EID: 48149111515     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.06.024     Document Type: Article

References (25)

1. Serruys P.W., de Jaegere P., Kiemanaij F., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331 (1994) 489-495
2. Fischman D.L., Lean M.B., Baim D.S., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331 (1994) 496-501
3. Cutlip D.E., Chauha M.S., Baim D.S., et al. Clinical restenosis after coronary stenting: perspectives from multi-center clinical trials. J Am Coll Cardiol 40 (2002) 2082-2089
4. Clark M.A., Bakhai A., Pelletier E.M., et al. Clinical and economic effects of coronary restenosis after percutaneous coronary intervention in a managed care population. Manag Care 14 42-4 (2005) 46-51
5. Cohen D.J., Houser F., Mack M., et al. Practice and outcomes of percutaneous coronary intervention in the community before drug-eluting stents: a report from the HCA database. J Invasive Cardiol 15 (2003) 121-127
6. Farb A., Sangiorgi G., Carter A.J., et al. Pathology of acute and chronic coronary stenting in humans. Circulation 99 (1999) 44-52
7. Mata L.A., Bosch X., David P.R., et al. Clinical and angiographic assessment 6 months after double vessel percutaneous coronary angioplasty. J Am Coll Cardiol 6 (1985) 1239-1244
8. Gruentzig A.R., King III S.B., Schlumpf M., et al. Long-tern follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience. N Engl Med 316 (1987) 1127-1132
9. Kent K.M., Bentivoglio L.G., Block P.C., et al. Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): report from the National Heart, Lung, and Blood Institute PTCA Registry. Am J Cardiol 53 (1984) 27C-31C
10. Ghali W.A., and Knudtson M.L. Overview of the Alberta provincial project for outcome assessment in coronary heart disease. On behalf of the APPROACH investigators. Can J Cardiol 16 (2000) 1225-1230
11. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 59 (1979) 607
12. Goldberg S.L., Loussararian A., De Gregorio J., et al. Predictors of diffuse and aggressive intra-stent restenosis. J Am Coll Cardiol 37 (2001) 1019-1025
13. Asakura M., Ueda Y., Nanto S., et al. Remodeling of in-stent neointima, which became thinner and transparent over 3 years: serial angiographic and angioscopic follow-up. Circulation 97 (1998) 2003-2006
14. Kimura T., Yokoi H., Nakagawa Y., et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 334 (1996) 561-566
15. Kuroda N., Kobayashi Y., Nameki M., et al. Intimal hyperplasia regression from 6 to 12 months after stenting. Am J Cardiol 89 (2002) 869-872
16. Walters D.L., Harding S.A., Walsh C.R., et al. Acute coronary syndromes is a common clinical presentation of in-stent restenosis. Am J Cardiol 89 (2002) 491-494
17. Bossi I., Klersy C., Black A., et al. In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat angioplasty. J Am Coll Cardiol 35 (2000) 1569-1576
18. Assali A.R., Moustapha A., Sdringola S., et al. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial). Am J Cardiol 98 (2006) 729-733
19. Chen M.S., John J.M., Chew D.P., et al. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 151 (2006) 1260-1264
20. Hoffmann R., Mintz G.S., Dussaillant G.R., et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 94 (1996) 1247
21. Kearney M., Pieczek A., Haley L., et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation 95 (1997) 1998
22. Kornowski R., Hong M.K., Tio F., et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 31 (1998) 224
23. Komatsu R., Ueda M., Naruko T., et al. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation 98 (1998) 224
24. Moreno P.R., Palacios I.F., Leon M.N., et al. Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am J Cardiol 84 (1999) 462-466
25. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591